Skip to main content
OpenTrials

Clinical trial condition

Intestinal Neoplasms

Explore clinical trials studying Intestinal Neoplasms. Study availability and eligibility vary by location and protocol.

67 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Intestinal Neoplasms trial results

Active, not recruiting

CRC Detection Reliable Assessment With Blood

NCT05551052

Conditions
Adenoma, Adenomas Colon, Colon Cancer, +29 more
Locations
  • Gastro SB Chula Vista, California, United States
  • SDG Clinical Research San Diego, California, United States
  • Medical Associates Research Group San Diego, California, United States
View Trial Details
Active, not recruiting

ASPIRIN Trial Belgium

NCT03464305

Conditions
Colon Cancer, Colonic Diseases, Colonic Neoplasms, +14 more
Locations
  • AZ Rivierenland campus Bornem (Sint Jozefkliniek) Bornem, Antwerpen, Belgium
  • AZ Klina Brasschaat, Antwerpen, Belgium
  • AZ Monica Deurne, Antwerpen, Belgium
  • UZ Antwerpen Edegem, Antwerpen, Belgium
View all 29 locations
View Trial Details
Completed

Drainage After Rectal Excision for Rectal Cancer

NCT01269567

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +12 more
Locations
  • CHU d'AMIENS Amiens, France
  • CH de BEAUVAIS Beauvais, France
  • Service de Chirurgie Digestive - Hôpital Saint-André - CHU de Bordeaux Bordeaux, France
  • Service de Chirurgie Générale et Digestive - Hôpital Beaujon Clichy, France
View all 22 locations
View Trial Details
Completed

A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis

NCT06048146

Conditions
Cancer of Rectum and Anus, Colorectal Neoplasms, Digestive System Diseases, +16 more
Locations
  • Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing, Beijing Municipality, China
View Trial Details
Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details
Completed

Exploratory Study of Rectal Mucus for Diagnosing Disease

NCT04659590

Conditions
Bowel Cancer, Bowel Disease, Digestive System Diseases, +9 more
Locations
  • Royal Cornwall Hospital Truro, Cornwall, United Kingdom
  • John Radcliffe Hospital Oxford, Oxfordshire, United Kingdom
  • Royal Shrewsbury & Telford Hospitals NHS Trust Shrewsbury, Shropshire, United Kingdom
  • Royal Devon & Exeter NHS Foundation Trust Exeter, United Kingdom
View Trial Details

Related conditions